These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19090549)

  • 1. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children.
    Bayram I; Erbey F; Celik N; Nelson JL; Tanyeli A
    Pediatr Blood Cancer; 2009 May; 52(5):571-4. PubMed ID: 19090549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
    Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
    Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
    Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
    J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
    Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
    Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
    Burns CP; Halabi S; Clamon G; Kaplan E; Hohl RJ; Atkins JN; Schwartz MA; Wagner BA; Paskett E
    Cancer; 2004 Jul; 101(2):370-8. PubMed ID: 15241836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer.
    Bauer J; Capra S; Battistutta D; Davidson W; Ash S;
    Clin Nutr; 2005 Dec; 24(6):998-1004. PubMed ID: 16140426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
    Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
    Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
    Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
    Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial.
    Ryan AM; Reynolds JV; Healy L; Byrne M; Moore J; Brannelly N; McHugh A; McCormack D; Flood P
    Ann Surg; 2009 Mar; 249(3):355-63. PubMed ID: 19247018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.
    Daneryd P; Svanberg E; Körner U; Lindholm E; Sandström R; Brevinge H; Pettersson C; Bosaeus I; Lundholm K
    Cancer Res; 1998 Dec; 58(23):5374-9. PubMed ID: 9850068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
    Smith HJ; Mukerji P; Tisdale MJ
    Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
    Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
    Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients].
    Gómez-Candela C; Villarino Sanz M; Horrisberger A; Loria Kohen V; Bermejo LM; Zamora Auñón P
    Nutr Hosp; 2011; 26(6):1385-93. PubMed ID: 22411387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional support strategies for malnourished cancer patients.
    van Bokhorst-de van der Schueren MA
    Eur J Oncol Nurs; 2005; 9 Suppl 2():S74-83. PubMed ID: 16437760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional treatment for ambulatory patients with acquired immunodeficiency virus infection and previous weight loss using a formula enriched with n3 fatty acids: a randomized prospective trial.
    De Luis DA; Bachiller P; Palacios T; Izaola O; Eiros Bouza JM; Aller R
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):449-54. PubMed ID: 20556924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of stage IV rectal cancer with whom EPA oral nutritional supplements could resolve cachectic condition and promote patient compliance with cancer chemotherapy].
    Hamamura K; Nakaya M; Nakagawa M; Miyazaki M; Miki C
    Gan To Kagaku Ryoho; 2011 May; 38(5):845-8. PubMed ID: 21566451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated malnutrition.
    Argilés JM
    Eur J Oncol Nurs; 2005; 9 Suppl 2():S39-50. PubMed ID: 16437757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.